| Complex immune dysregulation in COVID-19 patients with severe respiratory failure EJ Giamarellos-Bourboulis, MG Netea, N Rovina, K Akinosoglou, ... Cell host & microbe 27 (6), 992-1000. e3, 2020 | 2389 | 2020 |
| mTOR-and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity SC Cheng, J Quintin, RA Cramer, KM Shepardson, S Saeed, V Kumar, ... science 345 (6204), 1250684, 2014 | 2314 | 2014 |
| Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity S Saeed, J Quintin, HHD Kerstens, NA Rao, A Aghajanirefah, F Matarese, ... science 345 (6204), 1251086, 2014 | 1825 | 2014 |
| Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes J Quintin, S Saeed, JHA Martens, EJ Giamarellos-Bourboulis, DC Ifrim, ... Cell host & microbe 12 (2), 223-232, 2012 | 1359 | 2012 |
| Swarm learning for decentralized and confidential clinical machine learning S Warnat-Herresthal, H Schultze, KL Shastry, S Manamohan, ... Nature 594 (7862), 265-270, 2021 | 959 | 2021 |
| A guiding map for inflammation MG Netea, F Balkwill, M Chonchol, F Cominelli, MY Donath, ... Nature immunology 18 (8), 826-831, 2017 | 926 | 2017 |
| Two phase 3 trials of adalimumab for hidradenitis suppurativa AB Kimball, MM Okun, DA Williams, AB Gottlieb, KA Papp, CC Zouboulis, ... New England Journal of Medicine 375 (5), 422-434, 2016 | 898 | 2016 |
| Azithromycin: mechanisms of action and their relevance for clinical applications MJ Parnham, VE Haber, EJ Giamarellos-Bourboulis, G Perletti, ... Pharmacology & therapeutics 143 (2), 225-245, 2014 | 877 | 2014 |
| Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis SC Cheng, BP Scicluna, RJW Arts, MS Gresnigt, E Lachmandas, ... Nature immunology 17 (4), 406-413, 2016 | 646 | 2016 |
| The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity MF Osuchowski, MS Winkler, T Skirecki, S Cajander, M Shankar-Hari, ... The Lancet Respiratory Medicine 9 (6), 622-642, 2021 | 623 | 2021 |
| Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial E Kyriazopoulou, G Poulakou, H Milionis, S Metallidis, G Adamis, ... Nature medicine 27 (10), 1752-1760, 2021 | 591 | 2021 |
| Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection MG Netea, EJ Giamarellos-Bourboulis, J Domínguez-Andrés, N Curtis, ... Cell 181 (5), 969-977, 2020 | 524 | 2020 |
| Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity CC Zouboulis, T Tzellos, A Kyrgidis, GBE Jemec, FG Bechara, ... British Journal of Dermatology 177 (5), 1401-1409, 2017 | 518 | 2017 |
| What causes hidradenitis suppurativa? L Ralf Paus, H Kurzen, I Kurokawa, GBE Jemec, L Emtestam, K Sellheyer, ... Experimental dermatology 17 (5), 455-456, 2008 | 505 | 2008 |
| Effect and safety of meropenem–vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: the TANGO II randomized clinical trial RG Wunderink, EJ Giamarellos-Bourboulis, G Rahav, AJ Mathers, ... Infectious diseases and therapy 7 (4), 439-455, 2018 | 484 | 2018 |
| Activate: randomized clinical trial of BCG vaccination against infection in the elderly EJ Giamarellos-Bourboulis, M Tsilika, S Moorlag, N Antonakos, A Kotsaki, ... Cell 183 (2), 315-323. e9, 2020 | 453 | 2020 |
| TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans B Ferwerda, MBB McCall, S Alonso, EJ Giamarellos-Bourboulis, ... Proceedings of the National Academy of Sciences 104 (42), 16645-16650, 2007 | 427 | 2007 |
| Carrier systems for the local delivery of antibiotics in bone infections K Kanellakopoulou, EJ Giamarellos-Bourboulis Drugs 59 (6), 1223-1232, 2000 | 426 | 2000 |
| Joosten MG Netea, F Balkwill, M Chonchol, F Cominelli, MY Donath, ... LAB, 2016 | 416 | 2016 |
| Current gaps in sepsis immunology: new opportunities for translational research I Rubio, MF Osuchowski, M Shankar-Hari, T Skirecki, MS Winkler, ... The Lancet infectious diseases 19 (12), e422-e436, 2019 | 402 | 2019 |
Helen GiamarellouProfessor of Internal Medicine, National and Kapodistrian University of Athens, Medical SchoolVerified email at med.uoa.gr
